Changes on cards for two important EU guidelines on clinical investigation of medical devices
This article was originally published in SRA
Changes to two important EU medical device guidelines – on competent authority assessment of a medical device clinical investigation, and on reporting serious adverse events associated with devices during a clinical investigation – will be presented before the European Commission's Medical Devices Experts Group on 28 May for approval1.
You may also be interested in...
In the first of a two-part article on transparency provisions for the new EU clinical trial portal, the Pink Sheet reports on aspects that sponsors must consider to protect commercially confidential information in their clinical trial applications. The second article will look at the approach taken by Merck and discuss outstanding hot topics in relation to transparency and CTIS.
An independent audit of the new EU Clinical Trials Information System has finally commenced, indicating that plans are on track for the EU Clinical Trial Regulation to be implemented from December 2021.
EU regulators have agreed on supplementary pharmacovigilance requirements applicable to COVID-19 vaccines following approval.